Conference on Retroviruses and Opportunistic Infections (CROI)

Healio brings you the highlights from the Conference on Retroviruses and Opportunistic Infections (CROI). Refer back to this page often for the latest news from CROI, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Novel HIV inhibitors safe, well-tolerated

March 12, 2019
SEATTLE — Researchers presented positive findings from early-stage clinical trials of two novel HIV inhibitors at CROI. At a news conference…
Meeting News

PrEP uptake increases nearly 30% among MSM at high risk for HIV

March 12, 2019
SEATTLE — Between 2014 and 2017, the proportion of high-risk men who have sex with men who are taking pre-exposure prophylaxis, or PrEP, for…
Meeting NewsPerspective

Tshepiso study: Preventive TB therapy not associated with poor pregnancy outcomes

March 12, 2019
SEATTLE — Initiating isoniazid preventive therapy for tuberculosis during pregnancy is not associated with a higher rate of poor maternal or…
Meeting News

Nutrition, sanitation interventions improve neurodevelopment in HIV-exposed children

March 11, 2019
SEATTLE — Researchers found that combining nutrition and sanitation interventions led to improved motor and cognitive development in children…
Meeting NewsPerspective

Initiating ART without CD4 testing increases early mortality risk

March 11, 2019
SEATTLE — Patients who initiate ART without pretherapy CD4 monitoring experience a higher risk for early mortality than those who are tested…
Meeting NewsPerspective

Opioid overdose deaths rising among people living with HIV

March 11, 2019
SEATTLE — Despite a more than 12% decrease in the overall rate of death among people living with HIV between 2011 and 2015 in the United…
Meeting NewsVideo

VIDEO: TB prevention critical among people with HIV

March 10, 2019
SEATTLE — Infectious Disease News spoke with Amita Gupta, MD, associate professor of infectious diseases at Johns Hopkins University School of…
Meeting NewsPerspective

Monthly injectable HIV treatment noninferior to daily oral therapy

March 9, 2019
SEATTLE — A monthly injectable two-drug regimen of cabotegravir and rilpivirine is noninferior to a daily three-drug oral regimen for the…
Meeting News

‘Reassured’: Short TB treatment safe in adults with HIV on dolutegravir

March 8, 2019
SEATTLE — A short-course drug regimen to prevent tuberculosis was found to be safe in patients with HIV on dolutegravir therapy, while not…
Meeting NewsPerspective

Pilot study finds HCV treatment safe in pregnancy

March 8, 2019
SEATTLE — A small pilot study of hepatitis C treatment in pregnant women found that their response to ledipasvir-sofosbuvir therapy is similar…

Meeting Calendar

The Annual Conference on Retroviruses and Opportunistic Infections (CROI)

March 4, 2019 - March 7, 2019